Skip to main content

Table 2 Odds ratios and adjusted odds ratios for NAFLD in quartiles of each parameter

From: Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes

Parameters

Unadjusted OR (95% CI)

P-value

Adjusted OR (95% CI)

P-value

TyG index

 Q1

1

 

1

 

 Q2

1.738 (1.071–2.822)

0.025

1.992 (1.142–3.475)

0.015

 Q3

3.08 (1.859–5.108)

< 0.001

2.942 (1.677–5.163)

< 0.001

 Q4

3.455 (2.060–5.795)

< 0.001

3.405 (1.900–6.102)

< 0.001

TyG-BMI

 Q1

1

 

1

 

 Q2

2.156 (1.348–3.448)

0.001

1.843 (1.096–3.098)

0.021

 Q3

4.754 (2.802–8.067)

< 0.001

3.661 (2.049–6.539)

< 0.001

 Q4

6.535 (3.704–11.529)

< 0.001

4.868 (2.576–9.200)

< 0.001

HOMA-IR

 Q1

1

 

1

 

 Q2

2.451 (1.539–3.904)

< 0.001

2.951 (1.732–5.026)

< 0.001

TG/HDL-C

 Q1

1

 

1

 

 Q2

1.566 (0.972–2.522)

0.065

1.356 (0.788–2.333)

0.271

 Q3

2.288 (1.393–3.760)

0.001

1.882 (1.079–3.281)

0.026

 Q4

4.171 (2.435–7.147)

< 0.001

2.772 (1.544–4.976)

0.001

  1. NAFLD Non-alcoholic fatty liver disease, TyG index a product of triglyceride and fasting glucose, TyG-BMI TyG index × BMI; HOMA-IR Homeostatic model assessment for insulin resistance; (μU/dL) × fasting blood glucose (mg/dL)/22.5; Q, quartile of these variables, that is, Q1 was < 25%,Q2 was 25–50%,Q3 was 50–75%, and Q4 was 75% and above, but HOMA-IR was only divided into dichotomy, Q1 was < 75%, and Q2 was 75% and above